FDA Inspection 918004 — Embera NeuroTherapeutics, Inc
The FDA completed an inspection of Embera NeuroTherapeutics, Inc on Mar 18, 2015 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 18, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Shreveport, LA (United States)
Additional Details
Sponsor, Contract Research Organization